Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens

被引:54
|
作者
Miles, Linde A. [1 ]
Garippa, Ralph J. [2 ]
Poirier, John T. [3 ,4 ,5 ]
机构
[1] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Pharmacol Grad Training Program, Baltimore, MD USA
[2] Mem Sloan Kettering Canc Ctr, RNAi Core Facil, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA
[5] Weill Cornell Med Coll, New York, NY USA
关键词
CRISPR; Libraries; Screening; sgRNA; ESSENTIAL GENES; RNA-INTERFERENCE; HUMAN-CELLS; CRISPR-CAS9; SYSTEM; HUMAN GENOME; CANCER; IDENTIFICATION; ACTIVATION; EXPRESSION; MICROARRAY;
D O I
10.1111/febs.13770
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The recently described clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology has proven to be an exquisitely powerful and invaluable method of genetic manipulation and/or modification. As such, many researchers have realized the potential of using the CRISPR/Cas9 system as a novel screening method for the identification of important proteins in biological processes and have designed short guide RNA libraries for an in vitro screening. The seminal papers describing these libraries offer valuable information regarding methods for generating the short guide RNA libraries, creating cell lines containing these libraries, and specific details regarding the screening workflow. However, certain considerations are often overlooked that may be important when planning and performing a screen, including which CRISPR library to use and how to best analyze the resulting screen data. In this review, we offer suggestions to answer some of these questions that are not covered as deeply in the papers describing the available CRISPR libraries for an in vitro screening.
引用
收藏
页码:3170 / 3180
页数:11
相关论文
共 50 条
  • [31] CRISPR/CAS9 Technologies
    Williams, Bart O.
    Warman, Matthew L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (05) : 883 - 888
  • [32] Advances in CRISPR/Cas9
    Zhu, Youmin
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [33] Examination of CRISPR/Cas9 design tools and the effect of target site accessibility on Cas9 activity
    Lee, Ciaran M.
    Davis, Timothy H.
    Bao, Gang
    EXPERIMENTAL PHYSIOLOGY, 2018, 103 (04) : 456 - 460
  • [34] In Vitro Evaluation of CRISPR/Cas9 Function by an Electrochemiluminescent Assay
    Liu, Weipeng
    Yu, Huiheng
    Zhou, Xiaoming
    Xing, Da
    ANALYTICAL CHEMISTRY, 2016, 88 (17) : 8369 - 8374
  • [35] Protocol for performing pooled CRISPR-Cas9 loss-of-function screens
    Mathiowetz, Alyssa J.
    Roberts, Melissa A.
    Morgens, David W.
    Olzmann, James A.
    Li, Zhipeng
    STAR PROTOCOLS, 2023, 4 (02):
  • [36] Increasing the performance of pooled CRISPR–Cas9 drop-out screening
    Benedict C. S. Cross
    Steffen Lawo
    Caroline R. Archer
    Jessica R. Hunt
    Joanne L. Yarker
    Alessandro Riccombeni
    Annette S. Little
    Nicola J. McCarthy
    Jonathan D. Moore
    Scientific Reports, 6
  • [37] CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
    Concordet, Jean-Paul
    Haeussler, Maximilian
    NUCLEIC ACIDS RESEARCH, 2018, 46 (W1) : W242 - W245
  • [38] CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact
    Ishizaki, Takahiro
    Hernandez, Sophia
    Paoletta, Martina S.
    Sanderson, Theo
    Bushell, Ellen S. C.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2022, 50 (03) : 1069 - 1079
  • [39] Adapting CRISPR Cas9 dropout screens to in vivo PDX models of acute leukemias
    Ludwig, R.
    Amend, D.
    Bahrami, E.
    Jeremias, I
    KLINISCHE PADIATRIE, 2022, 234 (03): : 183 - 183
  • [40] Clonal dynamics limits detection of selection in tumour xenograft CRISPR/Cas9 screens
    Lee, Tet Woo
    Hunter, Francis W.
    Tsai, Peter
    Print, Cristin G.
    Wilson, William R.
    Jamieson, Stephen M. F.
    CANCER GENE THERAPY, 2023, 30 (12) : 1610 - 1623